Tag: cell therapy market insights

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Will the Cell Therapy Market Evolve in Terms of Growth and Size by 2029?

The market size for cell therapy has seen a quick expansion in the past few years. It’s projected to rise from $14.56 billion in 2024 to $16.87 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.8%. Factors contributing to the growth during the historical period include early investigations and discoveries, regulatory accomplishments, clinical research and trials, early adopting firms and innovators, as well as market reception and perception.

The market size of cell therapy is anticipated to experience significant expansion in the upcoming years. It’s projected to reach “$28.67 billion by 2029 with a compound annual growth rate (CAGR) of 14.2%. This surge during the prediction period is due to factors such as societal and ethical considerations, trends in investments and funding, demand from patients or consumers, the state of healthcare facilities, and fast-paced innovation cycles. The forecast period will also see key trends like personalized medicine, the rise of target-specific treatments, advancements in gene editing technologies, the broadening scope of stem cell research, improvements in immunotherapy, and manipulation of the microenvironment.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What factors are expected to fuel Cell Therapy market growth in the coming years?

The surge in chronic diseases has contributed to the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) characterizes chronic disease as an illness lasting a year or more that necessitates medical care, hinders daily activities, or both. This includes conditions like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells have the potential to assist patients with conditions such as spinal cord injuries, type 1 diabetes, Parkinson’s disease, heart disease, cancer, and osteoarthritis. As an illustration, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health organization in the U.S., disclosed significant advancements in public health initiatives. Heart disease or stroke lead to the death of over 944,800 Americans annually, representing more than one-third of all deaths. In the U.S., yearly cancer diagnoses are approximately 1.7 million individuals, with over 600,000 ultimately succumbing to the disease, making it the second leading cause of death. Furthermore, over 38 million Americans have diabetes, and another 98 million adults are prediabetic, thus increasing their potential for developing type 2 diabetes. Diabetes can trigger serious complications like heart disease, renal failure, and blindness. Meanwhile, obesity affects 20% of children and 42% of adults, thereby increasing susceptibility to chronic diseases such as type 2 diabetes, heart disease, and certain cancers. The escalating prevalence of chronic diseases has intensified the need for cell therapies, thereby facilitating the expansion of the cell therapy market.

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Future Market Trends Are Projected For The Cell Therapy Industry?

Major participants in the market are tactically associating and working together to broaden their range of products and extend their coverage across different regions. Ajinomoto Co Inc., a food firm based in Japan, took over Forge Biologics for a sum of $620 million in November 2023. This procurement is part of Ajinomoto Co Inc.’s strategy to enhance its worldwide competency in AAV and plasmid gene therapy manufacturing, thereby amplifying its current contract development and manufacturing services. Forge Biologics, on the other hand, is a biotechnology firm in the US that focuses on progressing cell therapy technologies for treating a variety of diseases.

What Are The Most Active Companies In The Cell Therapy Market Today?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Which Regional Markets Are Attracting The Most Investment In Cell Therapy?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Cell Therapy Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market for cell therapy has witnessed substantial growth in recent years. The size of the market is projected to surge from $14.56 billion in 2024, and reach a value of $16.87 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. This past period of growth is due largely to early exploration and discoveries, regulatory milestones, clinical experiments and research, the willingness of early adopters and innovative corporations to implement the technology, and favorable market acceptance and perception.

The market size of cell therapy is projected to witness a swift expansion in the coming years, with an estimated rise to $28.67 billion in 2029, featuring a compound annual growth rate (CAGR) of 14.2%. The forecast period’s growth may be due to ethical and societal considerations, investment and funding patterns, consumer or patient demand, healthcare infrastructure, and fast innovation cycles. Key trends during the forecast period encompass personalized medicine, burgeoning targeted treatments, gene editing technologies, an extension in stem cell research, advancements in immunotherapy, and manipulation of the microenvironment.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Cell Therapy Market?

The cell therapy market is growing due to the increasing incidence of chronic diseases. Chronic diseases, as defined by the US Centers for Disease Control and Prevention (CDC), are conditions that persist for a year or more and require medical attention, limit daily activities, or both. These ailments include heart disease, cancer, diabetes, and Parkinson’s disease. Patients with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis can potentially derive advantages from stem cells. In July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, issued considerable revise on public health strategies. Heart disease or stroke kill over 944,800 Americans annually, representing more than one-third of all deaths. Furthermore, cancer is diagnosed in 1.7 million individuals in the U.S. every year, with over 600,000 succumbing to the ailment, which is the second top cause of death. Over 38 million Americans are affected by diabetes, with an additional 98 million adults being prediabetic, raising the chance for type 2 diabetes. Diabetes can cause serious complications such as heart disease, kidney failure, and loss of vision. Obesity affects 20% of kids and 42% of adults, thereby increasing the risk of chronic diseases like type 2 diabetes, heart disease, and specific cancers. The increasing prevalence of chronic diseases escalated the necessity for cell therapies, contributing to the cell therapy market’s expansion.

Which Primary Segments of the Cell Therapy Market Are Driving Growth and Industry Transformations?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Cell Therapy Market?# Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Most Significant Market Trends in the Cell Therapy Market?

Top industry contenders are tactically forging partnerships and collaborations to widen their product range and enhance their geographic footprint. In November 2023, Ajinomoto Co Inc., a Japanese food corporation, purchased Forge Biologics for a whopping $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide abilities in AAV and plasmid gene therapy production, further enriching and enhancing its current contract development and manufacturing services. Forge Biologics, a biotech company based in the US, is committed to the development of cell therapy technologies for the treatment of a variety of diseases.

View the full report here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Parameters Are Used to Define the Cell Therapy Market?

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Cell Therapy Market Growth Evolved From 2024 To 2025, And What’s Ahead?#_x000D_

The market for cell therapy has witnessed substantial growth in recent years. The size of the market is projected to surge from $14.56 billion in 2024, and reach a value of $16.87 billion in 2025, with a compound annual growth rate (CAGR) of 15.8%. This past period of growth is due largely to early exploration and discoveries, regulatory milestones, clinical experiments and research, the willingness of early adopters and innovative corporations to implement the technology, and favorable market acceptance and perception._x000D_

_x000D_

The market size of cell therapy is projected to witness a swift expansion in the coming years, with an estimated rise to $28.67 billion in 2029, featuring a compound annual growth rate (CAGR) of 14.2%. The forecast period’s growth may be due to ethical and societal considerations, investment and funding patterns, consumer or patient demand, healthcare infrastructure, and fast innovation cycles. Key trends during the forecast period encompass personalized medicine, burgeoning targeted treatments, gene editing technologies, an extension in stem cell research, advancements in immunotherapy, and manipulation of the microenvironment._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Cell Therapy Market?#_x000D_

The cell therapy market is growing due to the increasing incidence of chronic diseases. Chronic diseases, as defined by the US Centers for Disease Control and Prevention (CDC), are conditions that persist for a year or more and require medical attention, limit daily activities, or both. These ailments include heart disease, cancer, diabetes, and Parkinson’s disease. Patients with spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis can potentially derive advantages from stem cells. In July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, issued considerable revise on public health strategies. Heart disease or stroke kill over 944,800 Americans annually, representing more than one-third of all deaths. Furthermore, cancer is diagnosed in 1.7 million individuals in the U.S. every year, with over 600,000 succumbing to the ailment, which is the second top cause of death. Over 38 million Americans are affected by diabetes, with an additional 98 million adults being prediabetic, raising the chance for type 2 diabetes. Diabetes can cause serious complications such as heart disease, kidney failure, and loss of vision. Obesity affects 20% of kids and 42% of adults, thereby increasing the risk of chronic diseases like type 2 diabetes, heart disease, and specific cancers. The increasing prevalence of chronic diseases escalated the necessity for cell therapies, contributing to the cell therapy market’s expansion._x000D_

_x000D_

#Which Primary Segments of the Cell Therapy Market Are Driving Growth and Industry Transformations?#_x000D_

The cell therapy market covered in this report is segmented – _x000D_

_x000D_

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy _x000D_

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies _x000D_

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy_x000D_

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine_x000D_

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy_x000D_

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy_x000D_

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Cell Therapy Market?# Market?#_x000D_

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Most Significant Market Trends in the Cell Therapy Market?#_x000D_

Top industry contenders are tactically forging partnerships and collaborations to widen their product range and enhance their geographic footprint. In November 2023, Ajinomoto Co Inc., a Japanese food corporation, purchased Forge Biologics for a whopping $620 million. This acquisition is intended to strengthen Ajinomoto Co Inc.’s worldwide abilities in AAV and plasmid gene therapy production, further enriching and enhancing its current contract development and manufacturing services. Forge Biologics, a biotech company based in the US, is committed to the development of cell therapy technologies for the treatment of a variety of diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Cell Therapy Market?#_x000D_

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Europe +44 7882 955267_x000D_

Asia & Others +44 7882 955267 & +91 8897263534_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Cell Therapy Market Grown from 2024 to 2025?

The market size for cell therapy has seen swift expansion in the past few years. It is set to escalate from $14.56 billion in 2024 to $17.02 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.9%. The growth observed in the historic period is a result of initial research and discoveries, regulatory achievements, clinical trials and studies, early adopters, as well as innovative companies, and the overall market acceptance and perception.

What Growth Rate Is Anticipated for the Cell Therapy Market in the Coming Years?

The market size of cell therapy is foreseen to experience a significant surge in the coming years, expanding to $29.28 billion by 2029 with a Compound Annual Growth Rate (CAGR) of 14.5%. The projected growth during this period is influenced by several factors, such as ethical and societal issues, investment trends, funding approaches, demands of patients/consumers, the health care infrastructure, and fast-paced innovation. The upcoming trends within this phase will be personalized medicine, development of targeted therapies, advancement in gene editing technologies, expansion of stem cell research, improvements in immunotherapy, and microenvironment manipulation.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Who Are the Leading Companies in the Cell Therapy Market?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

What Are the Key Drivers of the Cell Therapy Market?

The escalating incidences of chronic illnesses have propelled the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines a chronic disease as a condition that persists for a year or longer necessitating medical care, inhibits daily activities, or both; this includes ailments like heart disease, cancer, diabetes, and Parkinson’s. Stem cells offer significant benefits to patients who suffer from conditions such as spinal cord injury, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. In July 2024, the CDC, a US-based national public health agency, released substantial updates related to public health strategies. Annually, heart disease or stroke strikes down over 944,800 Americans, constituting over a third of all deaths. In the US, cancer is diagnosed in 1.7 million people annually, resulting in over 600,000 deaths, emerging as the second most frequent cause of death. Additionally, over 38 million Americans are living with diabetes, while another 98 million adults are prediabetic, at a heightened risk of developing type 2 diabetes. Diabetes can result in grave complications including heart disease, kidney failure, and blindness. Obesity, affecting 20% of children and 42% of adults, exacerbates the risk of chronic diseases such as type 2 diabetes, heart disease, and specific cancers. Consequently, the escalating incidence of chronic diseases has spurred the demand for cell therapies, fueling the expansion of the cell therapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

What Are the Key Market Segments in the Cell Therapy Industry?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

What Are the Latest Trends in the Cell Therapy Market?

Critical players in the market are tactically forming alliances and collaborations to broaden their product range and deepen their global footprint. Ajinomoto Co Inc., a food corporation from Japan, purchased Forge Biologics for $620 million in November 2023. This move was designed to enhance Ajinomoto Co Inc.’s worldwide prowess in AAV and plasmid gene therapy production, thus strengthening its current contract development and manufacturing services. Forge Biologics, situated in the United States, is a biotech firm committed to furthering cell therapy technologies for treating numerous illnesses.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Are the Key Regional Markets in the Cell Therapy Industry?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

This Report Delivers Insight On:

1. How big is the cell therapy market, and how is it changing globally?

2. Who are the major companies in the cell therapy market, and how are they performing?

3. What are the key opportunities and risks in the cell therapy market right now?

4. Which products or customer segments are growing the most in the cell therapy market?

5. What factors are helping or slowing down the growth of the cell therapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the cell therapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Fast Is The Cell Therapy Market Expected to Grow Between 2025 And 2029?#_x000D_

The market size of cell therapy has seen a rapid expansion over the past few years. The market, which is expected to rise from $14.56 billion in 2024 to $17.02 billion in 2025, will have a compound annual growth rate (CAGR) of 16.9%. This growth during the historical period can be credited to initial research and breakthroughs, regulatory achievements, clinical tests and studies, early adopters, and trailblazing firms, as well as market approval and perception._x000D_

_x000D_

The market size of cell therapy is projected to experience a swift expansion in the coming years, growing to a worth of $29.28 billion in 2029, with a compound annual growth rate (CAGR) of 14.5%. The growth during the forecasted period is attributed to factors such as ethical and societal factors, investment trends and funding, consumer or patient demand, development in healthcare infrastructure, and the speed of innovation cycles. Noteworthy trends during these years include the rise in personalized medication, advancing targeted treatments, expansion in gene editing technologies, the growth of stem cell research, developing immunotherapy, and the manipulation of the microenvironment._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp_x000D_

_x000D_

#Which Primay Drivers Are Accelerating Growth in the Cell Therapy Market?#_x000D_

The escalation in the occurrence of chronic health conditions has played a pivotal role in the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) describes chronic diseases as ailments that persist for over one year or require ongoing medical treatment, hampering daily functions, or even both. This could include diseases like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells have proven to be beneficial for patients suffering from ailments such as spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, the Centers for Disease Control and Prevention (CDC), a national public health agency in the US, released significant updates concerning public health initiatives. Each year, heart disease or stroke claims the lives of over 944,800 Americans, amounting to more than a third of total deaths. Meanwhile, cancer, the second leading cause of death, is diagnosed in 1.7 million individuals in the U.S. annually, and causes over 600,000 deaths. Furthermore, over 38 million Americans are living with diabetes, and nearly 98 million adults are prediabetic, which raises their risk of developing type 2 diabetes. Diabetes can result in severe complications such as heart disease, kidney failure, and blindness. Moreover, obesity, affecting 20% of children and 42% of adults, further increases the risk of chronic diseases including type 2 diabetes, heart disease, and specific types of cancer. The escalating incidence of chronic diseases has boosted the demand for cell therapies, and in turn, has bolstered the growth of the cell therapy market._x000D_

_x000D_

#Which Primary Segments of the Cell Therapy Market Are Driving Growth and Industry Transformations?#_x000D_

The cell therapy market covered in this report is segmented –_x000D_

_x000D_

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy_x000D_

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies_x000D_

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications_x000D_

_x000D_

Subsegments:_x000D_

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy_x000D_

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine_x000D_

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy_x000D_

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy_x000D_

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Cell Therapy Market?# Market?#_x000D_

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Which Technological Trends Are Reshaping the Cell Therapy Industry Dynamics?#_x000D_

Major market participants are tactically forming partnerships and alliances to diversify their product offerings and extend their reach globally. For instance, in November 2023, Ajinomoto Co Inc., a renowned food corporation from Japan, took over Forge Biologics at a deal worth $620 million. The objective of this acquisition is to boost Ajinomoto Co Inc.’s worldwide effectiveness in AAV and plasmid gene therapy production, thereby enhancing and fortifying its pre-existing contract development and manufacturing services. Forge Biologics is an American biotech firm committed to the progression of cell therapy technologies aimed at treating a variety of diseases._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Cell Therapy Market?#_x000D_

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Drivers Are Shaping the Growth and Development of theCell Therapy Market?

The cell therapy market has seen a surge due to an increase in chronic diseases. Chronic disease, which lasts for a year or longer, necessitates medical treatment, restricts daily activities, or both, has grown in instances such as heart disease, cancer, diabetes, and Parkinson’s disease, as per the US Centers for Disease Control and Prevention (CDC). Stem cells have proven to be beneficial for a variety of health issues, including spinal cord damage, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. Significant updates were made in July 2024, according to the CDC, a national public health agency based in the US, regarding public health programs. Over 944,800 Americans die from heart disease or stroke each year, representing more than a third of all deaths. Cancer, the second leading cause of death in the U.S., claims over 600,000 lives annually, with 1.7 million newly diagnosed cases each year. Additionally, over 38 million Americans are diabetic, and nearly 98 million are on the verge of being diabetic, increasing the likelihood of them developing type 2 diabetes. Diabetes can have serious health consequences, such as heart disease, kidney failure, and vision loss. Obesity, which affects 20% of children and 42% of adults, increases the risk of chronic diseases such as type 2 diabetes, heart disease, and certain cancers. Due to the increasing prevalence of these chronic diseases, the demand for cell therapies has increased, which directly impacts the expansion of the cell therapy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

#What Are the Key Projections for the CAGR of the Cell Therapy Market From 2025 to 2034?

In recent times, the cell therapy market’s dimensions have witnessed significant expansion. The market is predicted to rise from a worth of $14.56 billion in 2024 to an estimated value of $17.02 billion in 2025, projecting a compound annual growth rate (CAGR) of 16.9%. Factors contributing to this quantum leap during the historic phase include preliminary research and findings, regulatory landmarks, clinical experimentation and research, early market patrons, and trailblazing corporations, as well as market endorsement and conception.

The market size of cell therapy is anticipated to witness a significant surge in the upcoming years, reaching a valuation of $29.28 billion by 2029 with a 14.5% compound annual growth rate (CAGR). This predicted expansion during the forecasted period can be credited to factors such as societal and ethical considerations, trends in investment and funding, demand from patients/consumers, the state of healthcare infrastructure, and swift cycles of innovation. Key trends projected to dominate the forecast period are personalized medicine, the development of targeted treatments, advancements in gene editing technologies, the broadening scope of stem cell research, progress in immunotherapy, and manipulation of the microenvironment.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

Which Cutting-Edge Market Trends Are Expected to Drive theCell Therapy Market’s Growth?

Top industry players are employing strategic alliances and collaborations to broaden their product range and geographic footprint. Ajinomoto Co Inc., a Japanese food corporation, took over Forge Biologics in November 2023, for $620 million as a part of this strategy. This acquisition is intended to strengthen Ajinomoto Co Inc.’s world-wide expertise in AAV and plasmid gene therapy manufacturing, augmenting and bolstering its current contract development and manufacturing services. Forge Biologics, the acquired US-based biotech company, specializes in progressing cell therapy technologies for the treatment of a wide array of diseases.

What Are the Leading Market Players Impacting theCell Therapy Market’s Growth Trend?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

How Are the Key Segments of the Cell Therapy Market Driving Opportunities and Innovations?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3393&type=smp

What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theCell Therapy Market?# Market Expansion?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Cell Therapy Market 2025, By The Business Research Company:

Cell Culture Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-cultures-global-market-report

Cellular Immunotherapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cellulars-immunotherapy-global-market-report

Cell Therapy Technologies Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the cell therapy market?

The size of the cell therapy market has expanded at a swift pace in the past few years. The market, which is forecasted to soar from $14.56 billion in 2024 to $17.02 billion in 2025, is expected to experience a compound annual growth rate (CAGR) of 16.9%. Factors contributing to the growth during the historical period include early research findings, regulatory breakthroughs, clinical trials and studies, the adoption by trailblazer businesses, and the receptiveness and perspective of the market.

What will be the cell therapy market size in the future?

The expectation is for the market size of supermarkets and hypermarkets to witness significant expansion in the coming years, reaching a value of $5414.75 billion in 2029, with a compounded annual growth rate (CAGR) of 7.3%. The acceleration predicted during this forecast period is due to factors such as the incorporation of e-commerce, health and wellness trends, initiatives towards sustainability, globalization trends, and innovations within store formats. Foreseen trends in this period are improved customer loyalty programmes, sourcing from local and regional markets, movements for contactless shopping, broadening of fresh and ready-to-eat products, and the application of data for inventory management.

Get your cell therapy market report here!

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What main drivers are fueling expansion in the cell therapy market?

The escalating occurrence of chronic ailments has contributed to the growth of the cell therapy market. Chronic diseases, as defined by the US Centers for Disease Control and Prevention (CDC), are conditions that persist for over a year, necessitating medical care, limiting routine activities, or both. These include conditions like heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells offer potential benefits to patients suffering from conditions like spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), cardiovascular disease, cancer, and osteoarthritis. In July 2024, the Centers for Disease Control and Prevention (CDC), a U.S-based national public health institution, publicized significant advancements in their public health endeavors. Every year more than 944,800 Americans lose their lives to heart disease or stroke, representing over one-third of all deaths. In the U.S, close to 1.7 million people are diagnosed with cancer annually, and over 600,000 lose their lives to it, making it the second biggest killer. Moreover, over 38 million Americans are living with diabetes, and an additional 98 million adults are in the prediabetic stage, thus increasing their likelihood of developing type 2 diabetes. Diabetes can result in serious health issues like heart disease, kidney failure, and loss of vision. Obesity affects one in five children and 42% of adults, thereby increasing the risk of chronic diseases such as type 2 diabetes, cardiovascular disease, and select cancers. The escalating prevalence of chronic diseases has amplified the demand for cell therapies and boosted the growth of the cell therapy market.

What key areas define the segmentation of the global cell therapy market?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Who are the dominant players expanding their reach in the cell therapy market?

Major companies operating in the cell therapy market include Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corp., Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics plc, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

How are evolving market trends shaping cell therapy Strategies?

Primary market participants are tactically forming alliances and collaborations to grow the company’s range of products and territorial existence. Ajinomoto Co Inc., a food corporation based in Japan, acquired Forge Biologics for $620 million in November 2023. The goal of this acquisition is to strengthen Ajinomoto Co Inc.’s worldwide abilities in AAV and plasmid gene therapy production, enhancing and solidifying its existing contract development and production services. Forge Biologics is a biotechnology firm based in the US, concentrating on the evolution of cell therapy technologies for the treatment of various illnesses.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3393

Which regions are emerging as leaders in the cell therapy market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Similar Reports By The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Injectable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Cell Therapy Market’s Growth Rate Evolve Over the Forecast Period to 2034?

In recent times, there has been a substantial growth in the cell therapy market size. The growth is expected to increase from $14.56 billion in 2024 to $17.02 billion in 2025, at a compound annual growth rate (CAGR) of 16.9%. Factors contributing to the growth in the historic period include preliminary research and findings, regulatory landmarks, clinical experiments and studies, early adopters, pioneering firms, and overall market acceptance and perception.

In the coming years, the cell therapy market is projected to experience swift expansion. The market is forecasted to reach $29.28 billion by the year 2029, with a compound annual growth rate (CAGR) of 14.5%. This growth during the forecast period can be primarily ascribed to factors such as ethical and societal issues, trends in investment and funding, patient demand, the state of healthcare infrastructure, and the pace at which innovation is happening. Key trends predicted for this period comprise personalized medicine, the rise of targeted treatments, advancements in gene editing technologies, expansion of stem cell research, developments in immunotherapy, and microenvironment manipulation.

What Strategic Factors Are Influencing the Accelerated Growth of the cell therapy Market?

The escalation in the occurrence of chronic illnesses has spurred the growth of the cell therapy market. The US Centers for Disease Control and Prevention (CDC) defines chronic diseases as conditions that last a year or more and necessitate medical intervention or interfere with regular activities, or both. Such diseases include heart disease, cancer, diabetes, and Parkinson’s disease. Stem cells can potentially benefit patients who suffer from spinal cord injuries, type 1 diabetes, Parkinson’s disease (PD), heart disease, cancer, and osteoarthritis. For instance, in July 2024, significant updates were announced by the CDC – a US-based national public health institution – about public health initiatives. Heart disease and stroke claim the lives of over 944,800 Americans annually, representing more than a third of all deaths. In the U.S., cancer is detected in approximately 1.7 million individuals per year, causing over 600,000 deaths, making it the second primary cause of death. Moreover, diabetes impacts over 38 million Americans, while nearly 98 million adults are prediabetic, which amplifies their risk of acquiring type 2 diabetes. Diabetes can lead to grave complications including heart disease, kidney failure, and blindness. Obesity impacts 20% of children and 42% of adults, enhancing the likelihood of chronic diseases such as type 2 diabetes, heart disease, and certain cancers. The increasing occurrence of these chronic diseases amplifies the demand for cell treatments, thereby promoting the growth of the cell therapy market.

Request Your Free Cell Therapy Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=3393&type=smp

Who Are the Influential Players Reshaping the Cell Therapy Market Landscape?

Major companies operating in the cell therapy market include:

• Celgene Corporation_x000D_

• JCR Pharmaceuticals Co. Ltd._x000D_

• Baxter Healthcare Corporation_x000D_

• Nipro Corp._x000D_

• Stempeutics Research Pvt. Ltd._x000D_

What New and Evolving Trends Are Having a Lasting Impact on the Cell Therapy Market?

Major market participants are tactically forming partnerships and collaborations to broaden their product range and widen their regional footprint. In November 2023, Ajinomoto Co Inc., a Japanese food corporation, purchased Forge Biologics with a deal worth $620 million. This acquisition is driven by Ajinomoto Co Inc.’s intention to strengthen its international skills in AAV and plasmid gene therapy production, thereby enhancing and reinforcing its existing contract development and manufacturing services. Forge Biologics, headquartered in the US, is a biotech firm that focuses on improving cell therapy innovations for treating a variety of diseases.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

What Are the Main Segments of the Cell Therapy Market, and How Are They Evolving?

The cell therapy market covered in this report is segmented –

1) By Technique: Stem Cell Therapy, Cell Vaccine, Adoptive Cell Transfer (ACT), Fibroblast Cell Therapy, Chondrocyte Cell Therapy

2) By Therapy Type: Allogeneic Therapies, Autologous Therapies

3) By Application: Oncology, Cardiovascular Disease (CVD), Orthopedic, Wound Healing, Other Applications

Subsegments:

1) By Stem Cell Therapy: Hematopoietic Stem Cell Transplantation, Mesenchymal Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy

2) By Cell Vaccine: Dendritic Cell Vaccine, Tumor-Infiltrating Lymphocyte (TIL) Vaccine, Antigen-Specific Cell Vaccine

3) By Adoptive Cell Transfer (ACT): CAR T-Cell Therapy, T-Cell Receptor (TCR) Therapy, Natural Killer (NK) Cell Therapy

4) By Fibroblast Cell Therapy: Dermal Fibroblast Therapy, Adipose-Derived Stem Cell Therapy

5) By Chondrocyte Cell Therapy: Autologous Chondrocyte Implantation (ACI), Chondral Graft Therapy

Which Geographic Locations Are Critical to the Growth of the Cell Therapy Market?

North America was the largest region in the cell therapy market in 2024. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Defining Aspects of the Cell Therapy Market Landscape?

Cell therapy refers to the replacement or repair of damaged tissue and/or cells through the transplantation of human cells. Numerous different types of cells may be used as part of a therapy or treatment for a number of diseases and disorders with the help of new technologies, inventive products, and infinite imagination. It is a form of treatment wherein a patient receives live cells via injection, grafting, or implant in order to produce a therapeutic result.

Browse Through More Similar Reports By The Business Research Company:

Anti-Viral Drug Therapy Global Market Opportunities And Strategies To 2030: COVID-19 Implications And Growth

https://www.thebusinessresearchcompany.com/report/anti-viral-drug-therapy-market

Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/plasmas-therapy-global-market-report

Injectable Drug Delivery Devices Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: